Katalog der Deutschen Nationalbibliothek

Springe direkt zu:

Katalog (Beta)

Wissensnetz

Person
Person

Person

Frank Stegelmann (1977-)

Arzt

Name

Frank Stegelmann

Zeit

1977- (Lebensdaten)

Ort

Nürnberg (Geburtsort)
Deutschland

Geschlecht

männlich

Akademischer Grad bzw. Titel

Dr. med. habil.

Beruf

Arzt (charakteristischer Beruf)

Variante

Frank Emil Friedrich Stegelmann

Weitere Angaben

Diss. Medizinische Fakultät an der Universität Erlangen-Nürnberg
Habilitation an der Medizinischen Fakultät der Universität Ulm für das Fach Innere Medizin, 2018

Datensatztyp

Person

GND-Nummer

131868632

Datensatz-ID

131868632

Beteiligt an

alle anzeigen

Addendum to the German Consensus Recommendations on Ponatinib in the Treatment of Chronic Myeloid Leukemia

Addendum to the German consensus recommendations on ponatinib in the treatment of chronic myeloid leukemia

Momelotinib zur Behandlung krankheitsbedingter Splenomegalie oder klinischer Symptome bei erwachsenen Patienten mit Myelofibrose und mittelschwerer bis schwerer Anämie

Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α : a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN)

Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α : a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN)

Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group

Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera : futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group

P1055: Clinical and genetic results of the phase IB/II TRIAL MPNSG-0212: ruxolitinib plus pomalidomide in myelofibrosis with anemia

Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV

Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study

Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management

Ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute leukemia: recommendations of a German Expert Consensus Panel with focus on cardiovascular management

Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV

Ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute leukemia: recommendations of a German expert consensus panel with focus on cardiovascular management

Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management

Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV

Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV

Expression von CCL5, Granulysin und Perforin in CD8+-T-Lymphozyten
Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

DNB-Portal